High-Mobility Group Box Protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein E-deficient mice

Peter Kanellakis, Alex Agrotis, Tin Soe Kyaw, Christine Koulis, Ingo Ahrens, Shuji Mori, Hideo K. Takahashi, Keyue Liu, Karlheinz Peter, Masahiro Nishibori, Alex Bobik

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Objective-: High-mobility group box protein 1 (HMGB1) is a DNA-binding protein and cytokine highly expressed in atherosclerotic lesions, but its pathophysiological role in atherosclerosis is unknown. We investigated its role in the development of atherosclerosis in ApoE-/- mice. Methods and results-: Apolipoprotein E-deficient (ApoE-/-) mice fed a high-fat diet were administered a monoclonal anti-HMGB1 neutralizing antibody, and the effects on lesion size, immune cell accumulation, and proinflammatory mediators were assessed using Oil Red O, immunohistochemistry, and real-time polymerase chain reaction. As with human atherosclerotic lesions, lesions in ApoE-/- mice expressed HMGB1. Treatment with the neutralizing antibody attenuated atherosclerosis by 55%. Macrophage accumulation was reduced by 43%, and vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression was attenuated by 48% and 72%, respectively. CD11c+ dendritic cells were reduced by 65%, and the mature (CD83+) population was reduced by 60%. Treatment also reduced CD4+ cells by nearly 50%. mRNAs in lesions encoding tumor necrosis factor-α and interleukin-1β tended to be reduced. Mechanistically, HMGB1 stimulated macrophage migration in vitro and in vivo; in vivo, it markedly augmented the accumulation of F4/80+Gr-1(Ly-6C)+ macrophages and also increased F4/80+CD11b+ macrophage numbers. Conclusion-: HMGB1 exerts proatherogenic effects augmenting lesion development by stimulating macrophage migration, modulating proinflammatory mediators, and encouraging the accumulation of immune and smooth muscle cells.

Original languageEnglish
Pages (from-to)313-319
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume31
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

HMGB1 Protein
Apolipoproteins E
Atherosclerosis
Macrophages
Diet
Neutralizing Antibodies
Vascular Cell Adhesion Molecule-1
Chemokine CCL2
DNA-Binding Proteins
High Fat Diet
Interleukin-1
Cell Size
Dendritic Cells
Smooth Muscle Myocytes
Real-Time Polymerase Chain Reaction
Tumor Necrosis Factor-alpha
Immunohistochemistry
Cytokines
Messenger RNA
Therapeutics

Keywords

  • atherosclerosis
  • HMGB1
  • macrophages

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

High-Mobility Group Box Protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein E-deficient mice. / Kanellakis, Peter; Agrotis, Alex; Kyaw, Tin Soe; Koulis, Christine; Ahrens, Ingo; Mori, Shuji; Takahashi, Hideo K.; Liu, Keyue; Peter, Karlheinz; Nishibori, Masahiro; Bobik, Alex.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, No. 2, 02.2011, p. 313-319.

Research output: Contribution to journalArticle

Kanellakis, Peter ; Agrotis, Alex ; Kyaw, Tin Soe ; Koulis, Christine ; Ahrens, Ingo ; Mori, Shuji ; Takahashi, Hideo K. ; Liu, Keyue ; Peter, Karlheinz ; Nishibori, Masahiro ; Bobik, Alex. / High-Mobility Group Box Protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein E-deficient mice. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2011 ; Vol. 31, No. 2. pp. 313-319.
@article{43625ff50fb042cfacc8e65d5ba5f770,
title = "High-Mobility Group Box Protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein E-deficient mice",
abstract = "Objective-: High-mobility group box protein 1 (HMGB1) is a DNA-binding protein and cytokine highly expressed in atherosclerotic lesions, but its pathophysiological role in atherosclerosis is unknown. We investigated its role in the development of atherosclerosis in ApoE-/- mice. Methods and results-: Apolipoprotein E-deficient (ApoE-/-) mice fed a high-fat diet were administered a monoclonal anti-HMGB1 neutralizing antibody, and the effects on lesion size, immune cell accumulation, and proinflammatory mediators were assessed using Oil Red O, immunohistochemistry, and real-time polymerase chain reaction. As with human atherosclerotic lesions, lesions in ApoE-/- mice expressed HMGB1. Treatment with the neutralizing antibody attenuated atherosclerosis by 55{\%}. Macrophage accumulation was reduced by 43{\%}, and vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression was attenuated by 48{\%} and 72{\%}, respectively. CD11c+ dendritic cells were reduced by 65{\%}, and the mature (CD83+) population was reduced by 60{\%}. Treatment also reduced CD4+ cells by nearly 50{\%}. mRNAs in lesions encoding tumor necrosis factor-α and interleukin-1β tended to be reduced. Mechanistically, HMGB1 stimulated macrophage migration in vitro and in vivo; in vivo, it markedly augmented the accumulation of F4/80+Gr-1(Ly-6C)+ macrophages and also increased F4/80+CD11b+ macrophage numbers. Conclusion-: HMGB1 exerts proatherogenic effects augmenting lesion development by stimulating macrophage migration, modulating proinflammatory mediators, and encouraging the accumulation of immune and smooth muscle cells.",
keywords = "atherosclerosis, HMGB1, macrophages",
author = "Peter Kanellakis and Alex Agrotis and Kyaw, {Tin Soe} and Christine Koulis and Ingo Ahrens and Shuji Mori and Takahashi, {Hideo K.} and Keyue Liu and Karlheinz Peter and Masahiro Nishibori and Alex Bobik",
year = "2011",
month = "2",
doi = "10.1161/ATVBAHA.110.218669",
language = "English",
volume = "31",
pages = "313--319",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - High-Mobility Group Box Protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein E-deficient mice

AU - Kanellakis, Peter

AU - Agrotis, Alex

AU - Kyaw, Tin Soe

AU - Koulis, Christine

AU - Ahrens, Ingo

AU - Mori, Shuji

AU - Takahashi, Hideo K.

AU - Liu, Keyue

AU - Peter, Karlheinz

AU - Nishibori, Masahiro

AU - Bobik, Alex

PY - 2011/2

Y1 - 2011/2

N2 - Objective-: High-mobility group box protein 1 (HMGB1) is a DNA-binding protein and cytokine highly expressed in atherosclerotic lesions, but its pathophysiological role in atherosclerosis is unknown. We investigated its role in the development of atherosclerosis in ApoE-/- mice. Methods and results-: Apolipoprotein E-deficient (ApoE-/-) mice fed a high-fat diet were administered a monoclonal anti-HMGB1 neutralizing antibody, and the effects on lesion size, immune cell accumulation, and proinflammatory mediators were assessed using Oil Red O, immunohistochemistry, and real-time polymerase chain reaction. As with human atherosclerotic lesions, lesions in ApoE-/- mice expressed HMGB1. Treatment with the neutralizing antibody attenuated atherosclerosis by 55%. Macrophage accumulation was reduced by 43%, and vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression was attenuated by 48% and 72%, respectively. CD11c+ dendritic cells were reduced by 65%, and the mature (CD83+) population was reduced by 60%. Treatment also reduced CD4+ cells by nearly 50%. mRNAs in lesions encoding tumor necrosis factor-α and interleukin-1β tended to be reduced. Mechanistically, HMGB1 stimulated macrophage migration in vitro and in vivo; in vivo, it markedly augmented the accumulation of F4/80+Gr-1(Ly-6C)+ macrophages and also increased F4/80+CD11b+ macrophage numbers. Conclusion-: HMGB1 exerts proatherogenic effects augmenting lesion development by stimulating macrophage migration, modulating proinflammatory mediators, and encouraging the accumulation of immune and smooth muscle cells.

AB - Objective-: High-mobility group box protein 1 (HMGB1) is a DNA-binding protein and cytokine highly expressed in atherosclerotic lesions, but its pathophysiological role in atherosclerosis is unknown. We investigated its role in the development of atherosclerosis in ApoE-/- mice. Methods and results-: Apolipoprotein E-deficient (ApoE-/-) mice fed a high-fat diet were administered a monoclonal anti-HMGB1 neutralizing antibody, and the effects on lesion size, immune cell accumulation, and proinflammatory mediators were assessed using Oil Red O, immunohistochemistry, and real-time polymerase chain reaction. As with human atherosclerotic lesions, lesions in ApoE-/- mice expressed HMGB1. Treatment with the neutralizing antibody attenuated atherosclerosis by 55%. Macrophage accumulation was reduced by 43%, and vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression was attenuated by 48% and 72%, respectively. CD11c+ dendritic cells were reduced by 65%, and the mature (CD83+) population was reduced by 60%. Treatment also reduced CD4+ cells by nearly 50%. mRNAs in lesions encoding tumor necrosis factor-α and interleukin-1β tended to be reduced. Mechanistically, HMGB1 stimulated macrophage migration in vitro and in vivo; in vivo, it markedly augmented the accumulation of F4/80+Gr-1(Ly-6C)+ macrophages and also increased F4/80+CD11b+ macrophage numbers. Conclusion-: HMGB1 exerts proatherogenic effects augmenting lesion development by stimulating macrophage migration, modulating proinflammatory mediators, and encouraging the accumulation of immune and smooth muscle cells.

KW - atherosclerosis

KW - HMGB1

KW - macrophages

UR - http://www.scopus.com/inward/record.url?scp=79551472972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551472972&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.110.218669

DO - 10.1161/ATVBAHA.110.218669

M3 - Article

C2 - 21088249

AN - SCOPUS:79551472972

VL - 31

SP - 313

EP - 319

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 2

ER -